Host cell factors are critical to all stages of the hepatitis C virus (HCV) life cycle. While many cellular proteins that regulate HCV genome synthesis have been identified, the mechanisms engaged in this process are incompletely understood. To identify novel cellular proteins involved in HCV RNA replication, we screened a library of small interfering RNAs (siRNAs) targeting 299 cellular factors, which principally function in RNA interactions. For the screen, a robust system was established using two cell lines (derived from Huh-7 and U2OS cells) that replicated tricistronic subgenomic replicons (SGRs). We found that the U2OS cell line gave lower levels of intracellular HCV RNA replication compared with Huh-7 cells and was more readily transfected by siRNAs. Consequently, increased gene silencing and greater effects on HCV replication were observed in the U2OS cell line. Thus, U2OS cells provided a suitable and more sensitive alternative to Huh-7 cells for siRNA studies on HCV RNA replication. From the screen, several cellular proteins that enhanced and suppressed HCV RNA replication were identified. One of the genes found to downregulate viral RNA synthesis, ISG15, is expressed in response to alpha interferon and may therefore partly contribute to the clearance of virus from infected individuals. A second gene that inhibited HCV RNA levels was the 59-39 exoRNase XRN1, which suggested a role for cellular RNA degradation pathways in modulating the abundance of viral genomes. Therefore, this study provides an important framework for future detailed analyses of these and other cellular proteins.
INTRODUCTION
Hepatitis C virus (HCV) possesses a single-stranded (ss), positive-sense RNA genome of approximately 9.6 kb . The RNA is translated to yield a polyprotein that is cleaved by cellular (signal peptidase and signal peptide peptidase) and virus-encoded proteases (the NS2-3 autoprotease and NS3-4A serine protease), thereby generating the mature HCV proteins. The nonstructural (NS) proteins NS3, NS4A, NS4B, NS5A and NS5B are located at punctate structures on the endoplasmic reticulum (ER) membrane, which represent viral replication complexes (RCs) (Egger et al., 2002; Gosert et al., 2003; Targett-Adams et al., 2008) . Although the NS3-NS5B proteins are essential for HCV RNA synthesis, replication is dependent on host cell factors. A number of cellular proteins that participate in HCV RNA replication have been identified (see below for references). However, characterization of the complete complement of cellular factors required for HCV replication remains undefined.
Small inhibitory RNA (siRNA) technology is a powerful approach to identify host cell factors that contribute to viral replication and as such, several groups have screened siRNA libraries targeting cellular genes. For example, screening with libraries that target protein kinases (Supekova et al., 2008) , transporter proteins and transcription factors (Ng et al., 2007) , previously documented HCV-interacting proteins (Randall et al., 2007) and proteins implicated in membrane-trafficking (Berger et al., 2009) has identified cellular components that play roles in the HCV life cycle. To determine additional host proteins, which are important for replication and/or translation of HCV RNA, we screened a siRNA library targeting cellular nucleotide-binding proteins. These genes principally encoded translation factors, ribosomal proteins, RNAbinding proteins and proteins involved in the interferon (IFN)-response pathway, since IFN-a is used for treating HCV-infected individuals (Soriano et al., 2009 ) and reduces replication of JFH1 subgenomic replicons (SGRs) in vitro (Targett-Adams & McLauchlan, 2005) . For exploratory purposes, genes in other categories were also selected and included genes encoding proteins involved in cell cycle control and the cellular mRNA degradation pathway. Effects on viral replication were examined in U2OS osteosarcoma as well as Huh-7 cells to investigate the relative sensitivity of HCV RNA synthesis to siRNA genetargeting in the two cell lines.
RESULTS

Construction and characterization of a tricistronic JFH1 subgenomic replicon
In establishing a robust system for library screening, we wished to avoid artefacts from cytotoxic effects of combining electroporation of RNA with siRNA transfection. Early experiments with such an approach consistently gave non-specific lowering of HCV RNA replication (data not shown). To address this problem, a tricistronic replicon, termed Tri-JFH1 (Fig. 1a ) was used to generate stable cell lines that constitutively synthesized HCV subgenomic RNA. Tri-JFH1 harboured the neomycin resistance gene (Neo) for drug selection and a luciferase reporter enzyme (Luc) for assessing levels of HCV RNA synthesis. The HCV internal ribosome entry site (IRES) directed translation of Neo, whereas translation of both Luc and the viral NS coding region was controlled by two separate encephalomyocarditis virus (EMCV) IRES sequences. Such tricistronic replicons have proven to be suitable for screening a siRNA library (Supekova et al., 2008) .
To characterize Tri-JFH1 replication, in vitro transcribed RNA was electroporated into Huh-7 and U2OS cells. U2OS cells are derived from an osteosarcoma and support Luc-JFH1 replication, albeit to a lower efficiency than Huh-7 cells (Targett-Adams & McLauchlan, 2005) , and represented an alternative cell line for screening the siRNA library. Cells were also electroporated with RNA encoding bicistronic control replicons Luc-JFH1 and Luc-JFH1-GND, and luciferase activity was measured over 72 h (Fig. 1b) . Enzyme activity from Luc-JFH1 was 65-fold higher by 72 h compared with the 4 h time point in Huh-7 cells, indicating efficient replication of SGR RNA. By contrast, Luc-JFH1-GND did not replicate (Fig. 1b, left  panel) . In U2OS cells, Luc-JFH1 gave luciferase values that never increased beyond those observed at 4 h, but did not decline in a similar manner to the GND control (Fig. 1b,  right panel) . Therefore, U2OS cells supported HCV replication but to a lesser extent than Huh-7 cells, consistent with previous results (Targett-Adams & McLauchlan, 2005) . Importantly, enzyme activity from Tri-JFH1 revealed a replication pattern that paralleled Luc-JFH1 in both cell lines, although luciferase values were slightly lower at each time point (Fig. 1b) . These data indicated that Tri-JFH1 replicated transiently in two cell lines known to support HCV viral replication.
Isolation of cell lines supporting autonomous replication of Tri-JFH1
Having established that Tri-JFH1 replicated efficiently in transient assays, RNA from the construct was introduced into Huh-7 and U2OS cells, which were subsequently passaged in the presence of G418 for several weeks. The resulting cell lines were termed Tri-Huh-7 and Tri-U2OS. To examine whether replication from Tri-JFH1 could be detected after multiple rounds of passage, cells from both lines were fixed and probed for viral NS5A and doublestranded (ds)RNA (Fig. 2a) . NS5A and dsRNA were detected in .95 % of cells, indicating that Tri-JFH1 replicated following G418 selection in a high proportion of cells. Interestingly, some Tri-U2OS cells gave a dsRNA signal, while NS5A expression was below detectable limits (Fig. 2a, white arrowheads) . By contrast, Tri-Huh-7 cells typically contained both dsRNA and NS5A. In parallel experiments, antibodies for detection of NS5A and dsRNA gave no signal in parental Huh-7 and U2OS cells, in agreement with published results (Targett-Adams et al., 2008) . To confirm the lower levels of NS proteins in Tri-U2OS cells, extracts from both cell lines were harvested at different times up to 72 h after seeding and examined by Western blot analysis for viral NS4B and NS5A (Fig. 2b) . Both proteins were detected at all time points in Tri-Huh-7 cells and increased in abundance over 72 h, which correlated with increasing cell confluency over the time period. By contrast, lower levels of NS5A were detected in Tri-U2OS cells and NS4B was never observed (Fig. 2b) . To further characterize HCV genome synthesis, total cellular RNA was extracted from Tri-Huh-7 and Tri-U2OS cells over 72 h and HCV RNA was quantified by Real-Time PCR (qRT-PCR) (Fig. 2c) . While RNA levels were relatively stable in both lines over 72 h, Tri-Huh-7 cells harboured HCV transcript levels approximately 40-fold greater than those detected in Tri-U2OS cells. These data confirmed that Tri-U2OS cells supported less Tri-JFH1 replication compared with Tri-Huh-7 cells. Nonetheless, constitutive replication of the Tri-JFH1 SGR was achieved in both cell lines. Tri-Huh-7 and Tri-U2OS cells were incubated at 37 6C for 24 h, then fixed and probed for NS5A (using NS5A antiserum) and dsRNA (using J2). White arrowheads indicate cells in which viral RNA, but not NS5A could be detected. Bar, 10 mm. (b-d) Equal numbers of Tri-Huh-7 and Tri-U2OS cells were seeded before extracts were prepared at 4, 24, 48 and 72 h for (b) Western blot analysis, (c) qRT-PCR and (d) luciferase assay. In (b), NS5A and NS4B were detected using NS5A antiserum and R1063, respectively. The hypo-(black arrowhead) and hyperphosphorylated (grey arrowhead) NS5A species are indicated and actin detection served as a loading control. In (c) and (d), respectively, qRT-PCR and luciferase assays were performed in duplicate, and error bars represent the value ranges at each time point. RQ, Relative quantification.
Since gene-silencing effects were to be assessed by variations in luciferase activity, we wished to ensure that Tri-JFH1 produced detectable levels of enzyme in both TriHuh-7 and Tri-U2OS cells following G418 selection. Thus, cells were seeded in parallel to those used for qRT-PCR analysis and analysed for luciferase activity over the same time period (Fig. 2d) . Both cell lines produced readily measurable levels of luciferase, which increased with confluency over 72 h. Although enzyme levels produced by Tri-U2OS cells were lower than those observed with TriHuh-7 cells, the difference in luciferase activity between the two cell lines (just over twofold at 72 h in Fig. 2d ) was less than the difference in RNA levels as quantified by qRT-PCR (40-fold by 72 h in Fig. 2c ). There are several possible mechanisms to account for this discrepancy, including greater stability of luciferase protein in U2OS cells, but comparative analysis on this aspect of the two cell lines was not examined further.
Selection of siRNAs that modify HCV RNA levels (i) Characterization of siRNA specific for HCV RNA sequences. To verify the specificity of siRNA gene silencing on HCV RNA replication, we established a robust control for comparative purposes. From previous reports, HCV replication is repressed by siRNA-targeting of regions within NS3 (Kapadia et al., 2003; Prabhu et al., 2005) , NS5B (Kapadia et al., 2003; Ng et al., 2007; Prabhu et al., 2005) or the 59 untranslated region (UTR) (Chevalier et al., 2007; Kanda et al., 2007; Kronke et al., 2004; Ng et al., 2007; Seo et al., 2003; Yokota et al., 2003) . The 59 UTR is the most conserved segment of the HCV genome and contains a viral IRES for cap-independent translation of the viral polyprotein (Tsukiyama-Kohara et al., 1992; Wang et al., 1993) . The IRES harbours RNA structures that can be divided into four domains (termed I-IV). A siRNA that targets domain III/IV is particularly effective at reducing HCV RNA replication (referred to as si313 in Chevalier et al., 2007) . Furthermore, this region is conserved across several HCV genotypes, including JFH1. Therefore, a siRNA identical in sequence to si313 was synthesized and termed siHCV (Fig. 3a) .
To confirm the suppressive effect of siHCV on viral RNA synthesis, tricistronic cell lines were transfected at a concentration of 50 nM and luciferase activity was measured over 72 h (Fig. 3b) . Additionally, cells prepared in parallel were transfected with 50 nM of scrambled siRNA sequence (siCon) as a control. Luciferase levels were consistently lower in both cell lines treated with siHCV than those transfected with control siRNA from 24 h onwards. The greatest decrease in enzyme levels for both cell lines was observed at 48 h post-transfection (20-and 45-fold lower in Tri-Huh-7 and Tri-U2OS cells, respectively; Fig. 3b ). Furthermore, the effects of siHCV were sustained over a longer period in Tri-U2OS cells compared with Tri-Huh-7 cells. By 72 h, luciferase values had recovered to sixfold lower in Tri-Huh-7 cells transfected with siHCV than those treated with siCon, whereas enzyme levels were 30-fold lower in Tri-U2OS cells. The suppressive effect of siHCV was confirmed by Western blot analysis, which indicated a reduced abundance of NS5A (in Tri-Huh-7 and Tri-U2OS cells) and NS4B (in Tri-Huh-7 cells) in siHCV-transfected cell lines (data not shown). To verify that lower luciferase activities mediated by siHCV were mirrored by equivalent reductions in HCV RNA, Tri-Huh-7 and Tri-U2OS cells were transfected with siHCV and siCon for 48 h before being examined by luciferase assay and qRT-PCR. Here, the effect of siHCV on luciferase activity was less pronounced but again, there was more of a reduction in Tri-U2OS cells compared with Tri-Huh-7 cells (Fig. 3c) . Importantly, the relative abundance of HCV RNA in both cell lines closely matched the patterns obtained by luciferase assay (Fig. 3c) . From these data, we concluded that siHCV inhibited HCV RNA synthesis in cells containing a tricistronic SGR and that replication was inhibited to a greater degree in Tri-U2OS compared with Tri-Huh-7 cells. Moreover, quantifying luciferase activity was judged to be an accurate surrogate measure of effects on HCV RNA levels.
(ii) Repression of HCV RNA replication by siRNA silencing of casein kinase I-a (CKI-a). Before screening the entire siRNA library, both Tri-Huh-7 and Tri-U2OS cells were validated further using a siRNA specific for a cellular gene implicated in HCV RNA replication. Cellular kinase CKI-a is involved in NS5A hyperphosphorylation and furthermore, silencing CKI-a by siRNA treatment reduces both NS5A hyperphosphorylation and viral RNA replication (Quintavalle et al., 2006 (Quintavalle et al., , 2007 . Hence, TriHuh-7 and Tri-U2OS cells were transfected with a siRNA targeting CKI-a (siCKI-a) and cell extracts were examined by Western blot analysis and luciferase assay (Fig. 4) . CKI-a levels were reduced in both cell lines transfected with siCKI-a compared with those transfected with siCon and the protein was more potently silenced in Tri-U2OS cells. Although NS5A seemed unaffected in Tri-Huh-7 cells, less of the hyperphosphorylated species of NS5A was detected in Tri-U2OS cells treated with siCKI-a compared with those transfected with siCon (Fig. 4 , compare blots for NS5A in a and b). This result is in agreement with the notion that CKI-a is involved in NS5A hyperphosphorylation (Quintavalle et al., 2006 (Quintavalle et al., , 2007 . Upon examination of luciferase levels expressed by Tri-Huh-7 cells, HCV replication was unaffected by siCKI-a treatment until 72 h post-transfection. At this time point, enzyme activity decreased by twofold (Fig. 4a) . By contrast, luciferase levels were reduced by 48 h in Tri-U2OS cells transfected with siCKI-a siRNA, indicating that Tri-JFH1 replication was inhibited earlier in this cell line. The decrease in reporter activity was greater still by 72 h and luciferase values were reduced by sevenfold compared with siContransfected cells (Fig. 4b) . This result confirmed that CKI-a modulates HCV RNA replication, possibly through influencing NS5A hyperphosphorylation. Moreover, Tri-JFH1 replication could be reduced in both cell lines by a siRNA targeting a cellular gene. Together with the data in Fig. 3(b) , our results demonstrate that siRNA transfection of Tri-U2OS cells results in greater reductions in HCV replication compared with Tri-Huh-7 cells. From further experiments with plasmids that express luciferase, the greater impact of siRNAs in U2OS cells is probably linked to a higher transfection efficiency for nucleic acids as compared with Huh-7 cells ( Supplementary Fig. S1 , available in JGV Online).
Screening of Huh-7 and U2OS cell lines harbouring Tri-JFH1 with a siRNA library Following the above validation, the siRNA library was screened in both Tri-Huh-7 and Tri-U2OS cells. Genes were targeted by three siRNAs complementary to different regions of their coding sequence at a final overall concentration of 75 nM (25 nM for each siRNA). The screen was performed in duplicate for both cell lines and luciferase activity was measured to quantify effects on replication and/or translation of the Tri-JFH1 SGR within cells. Each screen included both positive (siHCV) and negative (siCon) controls, and cell viability was assayed to ensure decreased luciferase levels did not result from cell death arising from targeting essential host components. The complete dataset from the screen, including the list of genes targeted by siRNAs, is shown in Supplementary  Figs S2-S8 and Tables S1-S4 (available in JGV Online).
Consistent with earlier results, luciferase values were more potently influenced by siRNA targeting in Tri-U2OS cells than Tri-Huh-7 cells. Consequently, changes (either increases or decreases) in luciferase activity of .50 % in Tri-U2OS cells and .25 % in Tri-Huh-7 cells were selected as criteria for identifying siRNA-targeted genes that affected viral replication/translation. Based on these criteria, 65 genes were identified that modulated luciferase activity. However, silencing of many of these genes also decreased cell viability. Therefore, those siRNAs that maintained cell viability values of .80 % were selected as having specific effects on the Tri-JFH1 SGR. This criterion reduced the set of cellular genes affecting luciferase activity in both cell lines to 15 (Fig. 5a and Table 1 ). Comparing the siRNA sequences against these genes with the sense or antisense strands of the Tri-JFH1 SGR revealed no matches and therefore any effects of the siRNAs were not mediated by targeting of subgenomic replicon RNA.
From the 15 identified genes, seven gave decreased luciferase enzyme levels upon silencing, implying that these genes promoted HCV RNA replication and/or translation. Silencing of small ribosomal protein S14 (RPS14) reduced luciferase activity without lowering cell viability. In addition, silencing RNA-binding motif, singlestranded interacting protein 2 (RBMS2) and heterogeneous nuclear ribonucleoprotein D (hnRNP D) led to significant decreases in luciferase levels with little impact on cellular viability. This effect was especially evident with RBMS2, where siRNA targeting reduced enzyme levels to~64 and 30 % (in Tri-Huh-7 and Tri-U2OS cells, respectively), yet cell viability barely deviated from 100 %. Other proteins implicated in aiding HCV replication included retinoblastoma binding protein 6 (RBBP6), programmed cell death 4 (PDCD4), zinc finger protein 653 (ZNF653) and an as yet undefined gene (GenBank accession no. XM_497121). With the exception of RPS14, decreases in luciferase activity were more pronounced in Tri-U2OS cells, further highlighting the greater sensitivity of this cell line to siRNA transfection.
Conversely, silencing of seven other genes gave increased luciferase activity in both cell lines, suggesting they encode proteins that repress HCV RNA replication and/or translation. The largest increases in luciferase levels were observed when targeting ISG15 ubiquitin-like modifier (ISG15) and 59-39 exoRNase 1 (XRN1). In both cases, enzyme activity increased more dramatically in Tri-U2OS compared with Tri-Huh-7 cells. Further studies are ongoing with regard to the role of these genes in the HCV life cycle. Silencing of other genes increased luciferase activity to a lesser extent and included RNA-binding protein S1 serinerich domain (RNSP1), IFN-stimulated exonuclease gene 20 kDa-like 2 (ISG20L2), ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 (ACAP2), eukaryotic initiation factor (eIF) 4A2 and eIF4G2.
One gene, tRNA methyltransferase 6 homologue (TRMT6), had opposing effects on luciferase activity upon silencing in the two cell lines. Luciferase levels increased by 36 % in TriHuh-7 cells treated with siRNAs targeting TRMT6 but were reduced by 52 % in Tri-U2OS cells treated identically. This gene was the sole example that had opposing effects in the two cell lines without reducing cell viability to less than 80 %.
Since the changes in luciferase activity could be related to targeting of the EMCV IRES, which directs translation of both the HCV NS proteins and the luciferase reporter in Tri-JFH1, we selected some siRNAs for effects on viral replication in HCV-infected cells (Fig. 5b) . Selected siRNAs were targeted against hnRNP D, RBMS2 (which reduced luciferase activity with Tri-JFH1), ISG20L2 and eIF4G2 (which increased luciferase activity with Tri-JFH1). Huh-7 Fig. 4 . CKI-a influences NS5A hyperphosphorylation and HCV replication. Equal numbers of (a) Tri-Huh-7 and (b) Tri-U2OS cells were seeded in parallel and transfected with 50 nM siCKI-a or siCon. Extracts were prepared at 4, 24, 48 and 72 h and processed for luciferase assay and Western blot analysis. Luciferase assays were performed in duplicate and error bars represent the value ranges at each time point. Statistical significance was calculated for the 24, 48 and 72 h time points. A two-sample unequal variance t-test gave statistical significance at P,0.01 for the 72 h time point in Tri-Huh-7 cells and at the 48 and 72 h time points in Tri-U2OS cells. The hypo-(black arrowhead) and hyperphosphorylated (grey arrowhead) species of NS5A are indicated and actin detection served as a loading control.
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On: Tue, 18 Dec 2018 09:09:20 cells were transfected with siRNAs against each gene and then infected with HCV virions generated by J6-JFH1, a chimeric construct that gives virus titres, which are about 10-fold greater than strain JFH1 (Jones et al., 2009) . At 48 h after infection (i.e. 72 h after transfection of siRNAs), siHCV reduced levels of HCV RNA to only 4 % of those detected using siCON (Fig. 5b) . siRNAs targeted against hnRNP D and RBMS2 lowered viral RNA levels to 21 and 33 %, respectively, compared with siCON. By contrast, ISG20L2 and eIF4G2 siRNAs increased the amount of HCV RNA to 160 and 239 % of those obtained with siCON. These data agree with the pattern of effects on HCV RNA replication with Tri-JFH1 and demonstrate that changes in the levels of host genes targeted by siRNAs influence the machinery for viral genome synthesis and not the non-HCV elements in Tri-JFH1.
DISCUSSION
HCV RNA synthesis occurs within discrete cytoplasmic complexes derived from cellular ER membranes containing all necessary replicative components including viral NS proteins, RNA and several host cell cofactors (Egger et al., 2002; Gosert et al., 2003; Mottola et al., 2002) . Here, we screened a library focussing mainly on cellular genes involved in RNA interactions in an attempt to identify novel proteins that influence translation and/or synthesis of HCV RNA.
The central aim was to establish a robust system for screening the siRNA library. Positive-and negative-control siRNAs, in addition to two cell lines harbouring tricistronic SGRs, were created for this purpose. It became clear that siRNAs consistently influenced HCV RNA replication and cell viability to a greater degree in U2OS cells compared with Huh-7 cells (Figs 3b, 4b and 5; Table 1 ). A combination of factors is likely to contribute to these characteristics. Firstly, U2OS cells are more efficiently transfected than Huh-7 cells ( Supplementary Fig. S1 ), presumably facilitating a greater quantity of siRNA delivery and increased gene silencing. Secondly, HCV genome synthesis occurs at a lower level in U2OS cells compared with Huh-7 cells (Targett-Adams & McLauchlan, 2005) . The basis for the difference in replication efficiencies in the two cell lines is unknown, but limiting quantities of cellular factors or differences in cellular pathways that contribute to viral genome synthesis are likely to play a critical role. Such factors or pathways may be more readily suppressed by siRNAs in U2OS cells, giving enhanced effects on HCV replication levels. Therefore, U2OS cells may be a useful surrogate cell line for HCV RNA replication-based siRNA studies. The objective of the siRNA library screen was to identify genes required for HCV genome replication and/or translation. The largest class of genes implicated in maintaining HCV RNA levels encoded ribosomal protein subunits (see Supplementary Tables and Figs) . Ribosomes consist of a small (40S) and large (60S) subunit, which together are composed of approximately 80 distinct proteins. The 40S subunit mediates interactions between tRNA anticodons and mRNA codons, while the 60S subunit catalyses peptide bond formation in the polypeptide chain (Steitz, 2008) . Domains II and III of the HCV IRES directly contact and position the 40S ribosomal subunit at the AUG codon for core protein, thus promoting cap-independent translation of the viral polyprotein (Honda et al., 1996a, b) . It was unsurprising that silencing genes encoding small and large ribosomal subunits yielded reduced HCV RNA levels and cellular viability. RPS14 was the only example of a ribosomal subunit that could be silenced without reducing cell viability to less than 80 % in both cell lines. Silencing RPS14 decreased luciferase levels substantially to~7 % (in Tri-Huh-7 cells) and~12 % (in Tri-U2OS cells), suggesting that the gene is worthy of further investigation.
Other genes that promoted HCV RNA replication included RBMS2 and hnRNP D. RBMS2 binds to ssRNA molecules (Kanaoka & Nojima, 1994) and therefore may bind to HCV RNA to facilitate replication. However, RBMS2 is poorly characterized and so its possible function in HCV RNA replication is unclear. Targeting hnRNP D mRNA decreased luciferase values in both cell lines and lowered HCV RNA levels in virus-infected cells. Following completion of the siRNA library screen, a report confirmed the gene contributes to translation of the viral genome (Paek et al., 2008) . In that study, hnRNP D functions as an IRES-specific cellular transacting factor (ITAF) that binds to domain II of the HCV IRES. The authors demonstrated that siRNA-mediated reduction of hnRNP D in cell lines containing mono-and bicistronic SGRs and JFH1-infected cells resulted in repression of viral RNA translation, but not replication (Paek et al., 2008) .
During the library screen, it became apparent that the system was useful for identifying genes that suppressed HCV replication/translation, where siRNA silencing relieved this repression. For example, targeting translation initiation factors eIF4A2 and eIF4G2 enhanced enzyme levels in both cell lines. These proteins, along with others, comprise the eIF4F complex that recognizes the modified nucleotide at the 59 end of cellular mRNA in order to initiate cap-dependent translation (Fraser & Doudna, 2007) . However, the eIF4F complex is unnecessary for HCV translation, since the IRES recruits the 40S ribosomal subunit directly in the presence of eIF2 and eIF3 (Ji et al., 2004; Pestova et al., 1998) . Because eIF4A2 and eIF4G2 are involved in mRNA translation, it is possible that their silencing results in an excess of free ribosomes, which are unable to translate cellular transcripts. Consequently, an increased quantity of HCV genomes may be able to interact with these free ribosomes, resulting in enhanced translation of proteins from the tricistronic SGR.
A potentially important finding revealed that silencing IFN-stimulated genes ISG15 and ISG20L2 increased viral replication, particularly in the case of ISG15, where siRNA treatment enhanced luciferase levels by more than threefold in the U2OS cell line. ISG20L2 is a 39-59 exoRNase that is involved in ribosome biogenesis (Coute et al., 2008) , although any further biological function has yet to be determined. In contrast, ISG15 is a relatively wellcharacterized ubiquitin homologue. Like ubiquitin, ISG15 is reversibly conjugated to cellular proteins by enzymes that activate, conjugate and finally ligate ISG15 to target proteins (Sadler & Williams, 2008) . While protein ubiquitination drives various cellular processes, the effect of ISG15 addition (referred to as ISGylation) to proteins is unclear. ISG15 is thought to act as an antiviral factor and interferes with the life cycles of several viruses, including human immunodeficiency virus type 1 (HIV-1) (Okumura et al., 2006) and Ebola virus (Malakhova & Zhang, 2008; Okumura et al., 2008 ). The precise mechanism by which ISG15 mediates inhibition of HCV replication is likely to be complex, since at least 160 cellular genes modified by ISG15 have been identified (Zhao et al., 2005) . We are currently exploring further the relationship between ISG15 and HCV genome synthesis.
One other gene worthy of note encoded XRN1, an exoRNase responsible for the 59-39 degradation of cellular mRNA molecules (Muhlrad et al., 1994) . This process occurs within processing bodies (P-bodies), which are cytoplasmic structures derived from translationally repressed mRNA and protein complexes that are returned to the translational machinery or degraded following decapping of the target mRNA by the Dcp1 : Dcp2 complex (Anderson & Kedersha, 2006; Parker & Sheth, 2007) . Silencing of XRN1 resulted in increased luciferase levels in Tri-Huh-7 and Tri-U2OS cells, substantially so in the latter. These results suggest that, like mRNAs, HCV RNA genomes are degraded by XRN1. This effect may not be limited to HCV, since similar increases in HIV replication have been detected upon XRN1 silencing (Chable-Bessia et al., 2009). HCV RNA is uncapped, therefore association with the Dcp1 : Dcp2 complex is presumably unnecessary. It would be interesting to examine whether XRN1 is able to degrade structured HCV RNA elements such as the IRES. This could lead to subsequent degradation of the remaining genome or alternatively, degradation of the IRES alone would be sufficient to prevent translation. Alternatively, the enhancing effect on HCV RNA levels by lowering XRN1 could be mediated indirectly through cell factors whose expression is regulated by XRN1-directed degradation. If such factors promote viral RNA replication, then their abundance could be increased in the absence of XRN1, thereby stimulating higher levels of viral genome synthesis. We are currently conducting further studies to examine these possibilities.
In conclusion, we have screened a siRNA library targeting cellular proteins and have assayed their effects on HCV genome replication. We establish that U2OS cells are a suitable alternative to Huh-7 cells for analysis of HCV RNA synthesis and that these cells may provide a more sensitive system for siRNA-based studies. Moreover, we have identified several novel cellular factors that enhance and repress HCV replication. These require further investigation as they may be important for the future development of more effective HCV therapies.
METHODS
Construction of Tri-JFH1, a tricistronic SGR. Tri-JFH1 required positioning of both the neomycin resistance and luciferase reporter genes upstream of the NS3-5B coding region for strain JFH1. Therefore, the HCV IRES, neomycin gene and EMCV IRES were amplified using forward (59-GAATTCTAATACGACTCACTA-39; incorporates an existing EcoRI site at the 59 terminus of the HCV IRES) and reverse primers (59-AGATCTACTCACCACTATGGCG-CCCAG-39; introducing a BglII site at the 39 terminus of the EMCV IRES) using neo-JFH1 (Targett-Adams & McLauchlan, 2005) as a template to produce a PCR fragment termed H-Neo-E. The Luc-JFH1 replicon harbours an HCV IRES that drives translation of the luciferase reporter gene and is flanked by EcoRI and BglII sites. Therefore, Luc-JFH1 DNA was digested using EcoRI and BglII, to excise the HCV IRES. H-Neo-E was then inserted between these sites in digested Luc-JFH1 plasmid DNA to produce Tri-JFH1.
Individual and library siRNAs. Positive-(siHCV) and negative-(siCon) control siRNAs and a library of 897 siRNAs targeting 299 cellular genes were supplied by Ambion. Each siRNA (1 nmol) was resuspended in dH 2 O to yield a stock concentration of 100 mM (siHCV and siCon) or 50 mM (library siRNAs). Each cellular gene was targeted by three siRNAs specific for different regions of the mRNA sequence.
Transfection of siRNA and plasmid DNA. siRNA transfections were performed using Lipofectamine RNAiMAX reagent (Invitrogen) according to manufacturer's instructions. Cells were seeded at 7610 4 in 24-well dishes containing transfection mixture, and luciferase and cell viability values were measured 48 h later. DNA transfections were performed using polyethylenimine (Polysciences). Cells were seeded at approximately 8610 5 in 35 mm dishes and allowed to adhere before addition of transfection reagents.
In vitro transcription and electroporation of RNA. Constructs harbouring Luc-JFH1, Tri-JFH1 and J6-JFH1 were linearized with XbaI and treated with Mung Bean nuclease as described previously (Targett-Adams & McLauchlan, 2005) . RNA was transcribed in vitro from linearized constructs using the T7 RiboMAX Express Large Scale RNA Production system (Promega) and introduced into Huh-7 and U2OS cells by electroporation (McLauchlan et al., 2002) . For J6-JFH1, supernatant-containing virus was removed from cells at 72 h, and the tissue culture infectious dose (TCID 50 ) was obtained in Huh-7 cells by limiting dilution assay (Lindenbach et al., 2005) .
Determination of luciferase activity. Cell extracts were prepared at appropriate time points and luciferase values measured using the Luciferase Assay system (Promega) and a Biotrace M3 luminometer (Biotrace). Data points were obtained in duplicate and representative data for each experiment are shown.
Real-time quantification of viral RNA. qRT-PCRs were performed as a two-step process. Firstly, cDNA was generated from total cellular RNA using a Taqman kit (Applied Biosciences) in accordance with manufacturer's instructions, typically in a final volume of 20 ml. Reverse transcription was performed in a ThermoHybaid PX2 Thermal Cycler as follows: (i) primer annealing at 25 uC for 10 min; (ii) strand elongation at 37 uC for 1 h; (iii) RT inactivation at 95 uC for 5 min. The second step assayed Real-Time PCR using cDNA obtained from the first step. Reactions typically contained 900 nM forward and reverse primers, 250 nM FAM JFH1 probe, 16 Taqman Fast Universal Mix and 2 ml of cDNA template in a total volume of 20 ml. Both primers [59-TCTGCGGAACCGGTGAGTAC-39 (nt 147-166) and 59-GCACTCGCAAGCACCCTATC-39 (nt 295-314)] and the probe [59-GGCCTTGTGGTACTG-39 (nt 277-291)] were complementary to sequences in the 59 UTR of the JFH1 genome. Reactions were performed using an Applied Biosciences 7500 Fast Real-Time PCR System. Reactions were heated to 95 uC for 20 s to allow denaturation of the cDNA. PCR was performed as follows: (i) dsDNA strand-separation at 95 uC for 3 s; (ii) primer annealing and strand elongation at 60 uC for 30 s. Steps (i) and (ii) were repeated 40 times. All qRT-PCRs were performed in triplicate and values normalized to endogenous GAPDH levels.
